USD 4.46
(-4.9%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 15.21 Million USD | -6.65% |
2022 | 16.3 Million USD | -1.21% |
2021 | 16.5 Million USD | -42.78% |
2020 | 28.83 Million USD | 29.57% |
2019 | 22.25 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 11.24 Million USD | -26.1% |
2024 Q2 | 11.84 Million USD | 5.37% |
2023 Q2 | 15.64 Million USD | 73.83% |
2023 Q3 | 12.3 Million USD | -21.38% |
2023 Q1 | 9 Million USD | -44.79% |
2023 FY | 15.21 Million USD | -6.65% |
2023 Q4 | 15.21 Million USD | 23.71% |
2022 Q3 | 18.58 Million USD | 6.21% |
2022 Q4 | 16.3 Million USD | -12.3% |
2022 FY | 16.3 Million USD | -1.21% |
2022 Q1 | 20.36 Million USD | 23.39% |
2022 Q2 | 17.5 Million USD | -14.05% |
2021 Q3 | 30.05 Million USD | -21.7% |
2021 FY | 16.5 Million USD | -42.78% |
2021 Q4 | 16.5 Million USD | -45.1% |
2021 Q2 | 38.38 Million USD | 21.86% |
2021 Q1 | 31.49 Million USD | 9.22% |
2020 FY | 28.83 Million USD | 29.57% |
2020 Q2 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 28.83 Million USD | 0.0% |
2019 FY | 22.25 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 99.904% |
Allurion Technologies Inc. | 41.85 Million USD | 63.648% |
Artivion, Inc. | 359.34 Million USD | 95.766% |
Avanos Medical, Inc. | 209.1 Million USD | 92.723% |
Butterfly Network, Inc. | 25.02 Million USD | 39.202% |
Butterfly Network, Inc. | 25.02 Million USD | 39.202% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 98.918% |
Boston Scientific Corporation | 9.49 Billion USD | 99.84% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | 98.465% |
Edwards Lifesciences Corporation | 694.9 Million USD | 97.81% |
Paragon 28, Inc. | 112.03 Million USD | 86.418% |
Glaukos Corporation | 383.73 Million USD | 96.035% |
Globus Medical, Inc. | 520.4 Million USD | 97.076% |
Inspire Medical Systems, Inc. | 24.84 Million USD | 38.759% |
Integer Holdings Corporation | 1.04 Billion USD | 98.538% |
Medtronic plc | 26.04 Billion USD | 99.942% |
Nevro Corp. | 221.82 Million USD | 93.141% |
Penumbra, Inc. | 234.34 Million USD | 93.507% |
Vicarious Surgical Inc. | 14.83 Million USD | -2.589% |
Smith & Nephew plc | 3.08 Billion USD | 99.507% |
Sonendo, Inc. | 40.35 Million USD | 62.291% |
STERIS plc | 3.38 Billion USD | 99.55% |
Stryker Corporation | 12.99 Billion USD | 99.883% |
Vapotherm, Inc. | 112.39 Million USD | 86.462% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 99.746% |